These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9193397)

  • 21. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia.
    Technol Eval Cent Assess Program Exec Summ; 2005 Mar; 19(19):1-6. PubMed ID: 15793938
    [No Abstract]   [Full Text] [Related]  

  • 23. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
    Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
    Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
    Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction].
    Raviele A; Gasparini G
    G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246
    [No Abstract]   [Full Text] [Related]  

  • 26. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG; Duong T; Bland JM; Malik M; Torp-Pederson C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
    J Hypertens; 2007 Feb; 25(2):307-13. PubMed ID: 17211237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sudden cardiac death (SCD) and guidelines for SCD].
    Andresen D
    Z Kardiol; 2004; 93 Suppl 1():I4-6. PubMed ID: 15021998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of risk factors in sudden cardiac death after myocardial infarction. II. Late ventricular potentials, rhythm disorders and myocardial damage].
    Dłuzniewski M; Kułakowski P; Grochowicz U; Budaj A; Senatorski M
    Kardiol Pol; 1987; 30(2):80-7. PubMed ID: 3626263
    [No Abstract]   [Full Text] [Related]  

  • 32. [Arrhythmia. 1. Arrhythmia as a cause of sudden death in acute myocardial infarction--prophylaxis].
    Rydén L; Werkö L
    Lakartidningen; 1971 Jun; 68():Suppl II:53-. PubMed ID: 5113224
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of beta-adrenergic blocking agents in preventing sudden cardiac death.
    Pitt B
    Circulation; 1992 Jan; 85(1 Suppl):I107-11. PubMed ID: 1345815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 35. Designing clinical trials in the post CAST era--where do we go from here?
    Dorian P
    Can J Cardiol; 1991 Mar; 7(2):105-7; discussion 110-2. PubMed ID: 2049682
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of ischemic heart disease to sudden death.
    Buja LM; Willerson JT
    J Forensic Sci; 1991 Jan; 36(1):25-33. PubMed ID: 2007875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute myocardial ischemia and ventricular arrhythmias in the pathogenesis of sudden cardiac death in coronary disease].
    Zehender M; Faber T; Brunner M; Grom A
    Z Kardiol; 2000; 89 Suppl 3():13-23. PubMed ID: 10810781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of arrhythmic death after myocardial infarction: does it affect timing of ICD implantation?
    Lombardi F
    Eur Heart J; 2005 Jul; 26(14):1350-2. PubMed ID: 15872027
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sudden cardiac death].
    Bayés de Luna A; Guindo J
    Med Clin (Barc); 1989 Apr; 92(16):630-6. PubMed ID: 2664379
    [No Abstract]   [Full Text] [Related]  

  • 40. Dead is dead--artificial definitions are no substitute.
    Gottlieb SS
    Lancet; 1997 Mar; 349(9053):662-3. PubMed ID: 9078192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.